Skip to main content
logo
Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
28.85
+2.09 (7.81%)
At close: Aug 26, 2026, 4:00 PM EDT
28.33
-0.52 (-1.80%)
After-hours: Aug 26, 2026, 7:41 PM EDT

Cue Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-164.11-26.6-40.67-50.73-53.01-44.16
Depreciation & Amortization
3.883.482.353.441.811.26
Other Amortization
0.020.040.040.040.03-
Loss (Gain) From Sale of Assets
0.030.03-0.090.160-0.02
Loss (Gain) From Sale of Investments
-0.21-0.21--0.23-0.32-0
Stock-Based Compensation
26.034.746.858.189.511.52
Other Operating Activities
82.50.130.130.13-0.17-3.04
Change in Accounts Receivable
-4.85-4.60.75-1.643.09-1.73
Change in Accounts Payable
0.121.13-0.680.770.080.52
Change in Unearned Revenue
-9.585.25-2.032.11-0.65-7.97
Change in Other Net Operating Assets
16.11-5.07-2.97-2.18-2.174.79
Operating Cash Flow
-50.05-21.69-36.33-39.96-41.81-38.84
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.12-0.18-0.07--0.17-0.91
Sale of Property, Plant & Equipment
0.040.040.100.010.02
Investment in Securities
0.210.21-25-24.4510
Investing Cash Flow
0.130.080.0325-24.619.11

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
----10-
Long-Term Debt Repaid
--4.5-4-2--
Net Debt Issued (Repaid)
-2.5-4.5-4-210-
Issuance of Common Stock
32.8130.7914.2413.8639.319.98
Repurchase of Common Stock
-----0.2-0.75
Other Financing Activities
9.5---4.56-
Financing Cash Flow
39.8226.2910.2411.8653.6619.23

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-10.14.68-26.05-3.1-12.76-10.5

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-50.17-21.86-36.4-39.96-41.98-39.75
Free Cash Flow Growth
------
Free Cash Flow Margin
-133.23%-79.60%-391.89%-727.89%-3371.65%-266.04%
Free Cash Flow Per Share
-11.07-6.92-19.38-26.20-35.33-38.12
Levered Free Cash Flow
-33.43-9.95-20.36-19.91-21.09-20.32
Unlevered Free Cash Flow
-33.32-9.77-19.9-19.17-20.68-20.32

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.060.210.6710.57-
Cash Income Tax Paid
-----0.5
Change in Working Capital
1.81-3.3-4.93-0.930.36-4.39
SEC Filings: 10-K · 10-Q